Use of venlafaxine in children and adolescents: A review of current literature

Pediatric psychopharmacology is hindered by the relative lack of controlled , empirical clinical trials [Shatzberg and Nemeroff, 1998: Washington, D.C. : The American Psychiatric Press, Inc. p 301-306], Psychiatric disorders in children and adolescents carry considerable morbidity impede development, ann carry a significant mortality by suicide. Therefore, the-e is a need fo r studies of antidepressants and other psychotropics lit children and adole scents. This article reviews the preliminary evidence that venlafaxine (Eff exor(TM)), a novel antidepressant, may Ee useful in children and adolescent s with a variety, of psychiatric disorders. (C) 2000 Wiley-Liss, Inc.